Immune Pharmaceuticals to Present at 18th Annual BIO...

2016-02-08T09:57:12-08:00

NEW YORK, Feb. 8, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP), “Immune”, a clinical-stage biopharmaceutical company announced today that Dr. Daniel Teper, Chief Executive Officer, will be presenting at ...